Proton therapy https://www.bioworld.com/rss en-us Use of mixed reality visualization to improve radiotherapy The University of Florida Health Proton Therapy Institute’s director of Physics, Perry Johnson, has filed for protection of a method for patient posture and alignment using mixed reality (MixR) visualization. http://www.bioworld.com/articles/707172 Fri, 12 Apr 2024 12:00:00 -0400 https://www.bioworld.com/articles/707172-use-of-mixed-reality-visualization-to-improve-radiotherapy patient-alignment-12april24.jpg WO2024064111-A1, “Systems and methods of aligning a patient with a medical device leveraging outside-in tracking.”Assignee: University of FloridaInventors: Johnson, Perry, B.IPC Codes: G06T 15/00; G06T 7/73; G06T 7/30; A61B 90/00; A61B 34/10Publication Date: March 28, 2024Earliest priority details: US2022408711, Sept. 21, 2022 Proton, heavy ion radiotherapy centers on rise: Medical Korea 2024 Medical Korea 2024 opened to a large audience in Seoul, South Korea for a two-day run to highlight advances in the medical field, including those in radiotherapy. http://www.bioworld.com/articles/706667 Fri, 15 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706667-proton-heavy-ion-radiotherapy-centers-on-rise-medical-korea-2024 Medical Korea 2024 Samsung Medical Center Proton Therapy Center director Hee Chul Park at Medical Korea 2024 in Seoul, South Korea. EU funding new type of PET scanner used to monitor proton therapy in cancer The Spanish National Research Council, CSIC, has just been awarded funding from the European Research Council to establish proof of concept for new type of flat-plate positron emission tomography scanner (PET) that can be attached to the patient’s body to accurately monitor cancer proton therapy results in real time. http://www.bioworld.com/articles/518365 Fri, 29 Apr 2022 13:00:00 -0400 https://www.bioworld.com/articles/518365-eu-funding-new-type-of-pet-scanner-used-to-monitor-proton-therapy-in-cancer José Maria Benlloch Baviera José Maria Benlloch Baviera, director of the Institute for Molecular Imaging Technologies (I3M) in Valencia, Spain. Study shows potential of Advanced Oncotherapy’s LIGHT proton therapy for resistant cancers Advanced Oncotherapy plc reported new findings demonstrating the potential ability and superiority of its next-generation proton therapy system, LIGHT, to treat resistant cancers. The findings build on research at the Mayo Clinic that highlighted the benefits of combining proton therapy (PT) with targeted small molecule damage repair inhibitors. http://www.bioworld.com/articles/504970 Fri, 19 Mar 2021 13:00:00 -0400 https://www.bioworld.com/articles/504970-study-shows-potential-of-advanced-oncotherapys-light-proton-therapy-for-resistant-cancers 3D rendering of LIGHT system LIGHT is next-generation proton therapy system that relies on a linear accelerator. Credit: Advanced Oncotherapy plc Varian integrates machine learning into proton treatment planning for the first time Palo Alto, Calif.-based Varian Medical Systems Inc. is no stranger to machine learning applications. It rolled out its first such software to guide photon-based radiotherapy treatment planning more than five years ago. Now, it’s expanding a similar approach for machine learning-driven patient matching and treatment guidance in proton treatment planning. http://www.bioworld.com/articles/434216 Mon, 06 Apr 2020 13:00:00 -0400 https://www.bioworld.com/articles/434216-varian-integrates-machine-learning-into-proton-treatment-planning-for-the-first-time Ethos radiotherapy system Ethos radiotherapy system. Credit: Varian Medical Systems Inc.